Fresenius Medical Care AGFMCQF 72 ROA % is 1.50% as of Mar. 2026, which is 55% below its 10-year median of 3.32. GuruFocus rates FMCQF with a GF Score™ of 72/100 and a GF Value™ of $47.44 (Fairly Valued). The stock has 4 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Fresenius Medical Care AG ranks better than 55.98% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Fresenius Medical Care AG's annualizedNet Income for the quarter that ended in Mar. 2026 was $543 Mil.
Fresenius Medical Care AG's average Total Assets over the quarter that ended in Mar. 2026 was $36,341 Mil. Therefore, Fresenius Medical Care AG's annualized ROA % for the quarter that ended in Mar. 2026 was 1.50%.
The historical rank and industry rank for Fresenius Medical Care AG's ROA % or its related term are showing as below:
FMCQF'
s ROA % Range Over the Past 10 Years
Min: 1.43 Med: 3.32 Max: 7.89
Current: 3
During the past 13 years, Fresenius Medical Care AG's highest ROA % was 7.89%. The lowest was 1.43%. And the median was 3.32%.
FMCQF's ROA % is ranked better than 55.98% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 1.75
vs FMCQF: 3.00
Fresenius Medical Care AG (OTCPK:FMCQF) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Fresenius Medical Care AG's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius Medical Care AG ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's ROA % distribution charts can be found below:
* The bar in red indicates where Fresenius Medical Care AG's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Fresenius Medical Care AG (FMCQF) has a ROA % of 1.50% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Fresenius Medical Care AG and its competitors. This is 55% below median its historical median of 3.32. Over the past decade, Fresenius Medical Care AG's ROA % has ranged from 1.43 to 7.89. According to the industry distribution chart, Fresenius Medical Care AG ranks #302 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 44%.
Is Fresenius Medical Care AG's ROA % too high?
Fresenius Medical Care AG's current ROA % of 1.50% is 55% below median its 10-year median of 3.32. Over the past 10 years, this metric has ranged from a low of 1.43 to a high of 7.89. The Healthcare Providers & Services industry median ROA % is 1.75. Fresenius Medical Care AG's value of 1.50% is 14.3% below this industry median. Based on the distribution chart, Fresenius Medical Care AG ranks #302 out of 686 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fresenius Medical Care AG has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #302 out of 686 companies for ROA %. This puts Fresenius Medical Care AG in the upper half of its industry. The industry median ROA % is 1.75. Fresenius Medical Care AG's value of 1.50% is 14.3% below this benchmark. Historically, Fresenius Medical Care AG's own ROA % has ranged from 1.43 to 7.89 over the past decade. While the company's 10-year median is 3.32 vs. the industry median of 1.75, Fresenius Medical Care AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.75, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius Medical Care AG's current ROA % of 1.50% is 14.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Fresenius Medical Care AG and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius Medical Care AG's current ROA % is 1.50%, which is 55% below median its own 10-year median of 3.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (FMCQF) is currently considered Fairly Valued. The stock's GF Value™ is $47.44, compared to a current price of $45.17 — trading 4.8% below its estimated fair value. The current ROA % is 1.50%, which is 55% below median its 10-year median of 3.32 and 14.3% below the Healthcare Providers & Services industry median of 1.75. Fresenius Medical Care AG's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Fresenius Medical Care AG (FMCQF), the current ROA % is 1.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius Medical Care AG (FMCQF) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued.
The current stock price of $45.17 is trading 4.8% below its estimated GF Value™ of $47.44.
GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.
Key valuation signals for FMCQF:
ROA %: 1.50% (55% below median its 10-year median of 3.32)
GF Value™: $47.44 vs. price of $45.17 (4.8% below fair value)
Industry Position: 14.3% below the Healthcare Providers & Services median (#302 of 686)
No single metric tells the full story. See the FMCQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
72GF Score
Get the complete analysis for FMCQF
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FMCQF has been successfully added to your 
